Repurposed Anti-Multiple Sclerosis Drug Fty720 Targets Carbapenem-Resistant Acinetobacter baumannii via Multiple Pathways. Wu Y, Pang Y, Yang H, Zhu L, et al. Curr Microbiol 2024;82:17.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wu Y, Pang Y, Yang H, Zhu L, et al. Repurposed Anti-Multiple Sclerosis Drug Fty720 Targets Carbapenem-Resistant Acinetobacter baumannii via Multiple Pathways. Curr Microbiol 2024;82:17.
PMID: 39607538